An Expanded Safety Study of Dapivirine Gel 4759 in Africa
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether dapivirine gel 4759 is safe for daily use
by healthy women in Kenya, Malawi, Rwanda, South Africa and Tanzania.